MDx Business Helps Meridian Q2 Revenues Spike 32 Percent

The firm's illumigene molecular testing platform and the Bioline reagents business acquired last year contributed to the revenue growth.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.